The merger announcement from Walgreens Boots Alliance and Rite Aid throws up an interesting question, writes Stephen Littlejohn. Will Walgreens be purveyor focused on retail sales or provider engaged with a transforming U.S. healthcare system?
Technology
Latest News
Advertisement
Advertisement
October 30, 2015.
October 30, 2015.
October 28, 2015.
October 28, 2015.
October 27, 2015.
October 26, 2015.
October 26, 2015.
October 22, 2015.
October 19, 2015.
October 19, 2015.
Medicine is entering a new era of “gene editing.” Instead of simply being able to “read” our genes, practitioners will be able to adapt and modify DNA sequencing in living cells to treat, cure, and even prevent disease. Defective genes responsible for life-threatening diseases can be rendered harmless by gene editing; it can also be used to develop new, precisely targeted biological drugs based on an individual’s distinct genetic markers. The full list of possibilities, in every area of the life sciences, is simply beyond imagination.
October 16, 2015.
October 09, 2015.
October 08, 2015.
October 08, 2015.
Advertisement
Advertisement
Trending on PharmExec
1
Brent Saunders: Eyeing New Horizons
2
TrumpRX Has a Blind Spot and It Can Redefine Patient Access
3
Lilly’s Retatrutide Displays Positive Topline Results in Successful Phase III Trial
4
The GLP-1 Gold Rush
5
